TANA, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 1.289
EU - Europa 1.130
AS - Asia 412
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
Totale 2.839
Nazione #
US - Stati Uniti d'America 1.284
IE - Irlanda 251
CN - Cina 236
SE - Svezia 214
IT - Italia 207
UA - Ucraina 145
TR - Turchia 108
GB - Regno Unito 105
FR - Francia 72
DE - Germania 68
IN - India 43
FI - Finlandia 29
AT - Austria 21
VN - Vietnam 16
RO - Romania 8
CA - Canada 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HK - Hong Kong 3
IR - Iran 3
RU - Federazione Russa 3
BE - Belgio 2
CL - Cile 2
EU - Europa 2
BR - Brasile 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
JP - Giappone 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 2.839
Città #
Chandler 265
Dublin 239
Jacksonville 209
Princeton 104
Ashburn 103
Dearborn 98
Southend 88
Izmir 79
Beijing 71
Nanjing 63
Altamura 47
Wilmington 35
Ann Arbor 34
Cambridge 29
Chieti 22
Seattle 19
Vienna 19
Nanchang 17
Dong Ket 16
Boardman 14
Washington 14
Gothenburg 12
Hebei 12
Kunming 12
Woodbridge 11
Pescara 10
Shenyang 9
Houston 8
Leawood 8
Rio Saliceto 8
Tianjin 8
Augusta 7
Grevenbroich 7
Monmouth Junction 7
Rome 7
San Mateo 7
Norwalk 6
Hangzhou 5
Jinan 5
Changchun 4
Fairfield 4
Falls Church 4
Hefei 4
Iglesias 4
Jiaxing 4
Toronto 4
Bisenti 3
Campodipietra 3
Catania 3
Changsha 3
Milan 3
Palermo 3
Ardabil 2
Brussels 2
Fuzhou 2
Guido 2
Helsinki 2
Hong Kong 2
Jesolo 2
Munich 2
New York 2
Ningbo 2
Quzhou 2
Vittuone 2
Zhengzhou 2
Agrigento 1
Andover 1
Bagno A Ripoli 1
Bangalore 1
Budapest 1
Eden Prairie 1
Edinburgh 1
Florence 1
Genova 1
Guangzhou 1
Haikou 1
Hanover 1
Indianapolis 1
Kemerovo 1
L'aquila 1
Lanzhou 1
Las Vegas 1
Laurel 1
Leipzig 1
London 1
Los Angeles 1
Manchester 1
Menlo Park 1
Modena 1
Mountain View 1
Mumbai 1
Notaresco 1
Novokuznetsk 1
O Fallon 1
Orange 1
Pune 1
Raleigh 1
Redwood City 1
Roseto Degli Abruzzi 1
San Benedetto Del Tronto 1
Totale 1.841
Nome #
Impact of migraine on fibromyalgia symptoms 154
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 113
Use of Contrast-enhanced ultrasound (CEUS) in systemic mastocytosis. Report of two cases 93
Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache 87
microRNA profiling in atherosclerosis, diabetes, and migraine 82
Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution 81
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? 80
Co-occurrence of pain syndromes 78
Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective 77
Multifactorial headache in patient with chorio-retinal tuberculosis granuloma 76
Sarcoidosis: Old certainties and new perspectives [La sarcoidosi: Vecchie certezze e nuove prospettive] 75
Acute acalculous cholecystitis and cardiovascular disease: a land of confusion 75
Sonographic assessment of a suspected biloma: a case report and review of the literature. 72
Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization. 72
Teaching neuroimages: a dangerous complication of spontaneous intracranial hypotension 71
Challenges in the diagnosis and treatment of neurosarcoidosis 70
NSAIDs for symptomatic treatment of headache 68
Immunopathogenesis of sarcoidosis and risk of malignancy: a lost truth? 64
Extrapulmonary sarcoidosis: A chameleon disease at imaging 64
Pitfalls of contrast-enhanced ultrasound (CEUS) in the diagnosis of splenic sarcoidosis 62
Muscle pain sensitivity in hypertensive patients with and without chronic pain 62
Severe non-traumatic bleeding, the answer is not in the blood 62
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 62
Can ultrasound give valuable clues in the diagnosis of bile leakage? 61
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 59
An unusual case of urine bag discoloration 58
Correlation between Migraine Severity and Cholesterol Levels 57
Ultrasound imaging of abdominal sarcoidosis: State of the art 57
Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications 56
Gallbladder infection by trematodes 55
Pain thresholds in women with chronic pelvic pain 55
Emphysematous pancreatitis associated with penetrating duodenal ulcer 55
Heterogeneous delayed enhancement of the liver after administration of ultrasound contrast agents: are we sure that it is a harmless phenomenon? 54
Splenic sarcoidosis remains a diagnostic challenge. 51
Athlete’s Heart: Diagnostic Challenges and Future Perspectives 50
Splenic involvement in sarcoidosis mimicking hypoechoic metastases in colon cancer 47
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes 47
Management of hyperuricemia and gout in obese patients undergoing bariatric surgery 47
Aliased Flow Signal Planimetry by Cardiovascular Magnetic Resonance Imaging for Grading Aortic Stenosis Severity: A Prospective Pilot Study 47
Neoangiogenesis is reduced in chronic tendinopathies of type II diabetic patients 46
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura 40
CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification 39
Clinical Features and Diagnosis of Cardiac Sarcoidosis 37
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 36
Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives 33
Authors’ Reply to Kindermann et al.’s Comment on: “Athlete’s Heart: Diagnostic Challenges and Future Perspectives” 32
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 31
Clinical Features, Histopathology and Differential Diagnosis of Sarcoidosis 25
Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis 24
Ultrasound assessment of SARS-CoV-2 pneumonia: a literature review for the primary care physician 20
Approach to COVID-19 in older adults and indications for improving the outcomes 19
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis 17
Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019 17
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis 14
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation 13
Long COVID and especially headache syndromes 4
A highly-detailed anatomical study of left atrial auricle as revealed by in-vivo computed tomography 3
New Therapeutic Options for Migraine 3
Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis 1
Totale 3.110
Categoria #
all - tutte 10.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019107 0 0 0 0 0 0 0 0 0 1 7 99
2019/2020612 147 29 17 0 65 67 87 44 15 68 63 10
2020/2021276 42 12 50 3 13 46 7 4 11 21 43 24
2021/2022296 4 6 7 57 31 6 4 12 31 19 39 80
2022/2023799 69 149 63 63 61 148 45 65 92 13 20 11
2023/2024428 24 10 38 18 55 133 108 33 1 8 0 0
Totale 3.110